{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "49897", "DateCompleted": {"Year": "1975", "Month": "10", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0037-9727", "JournalIssue": {"Volume": "149", "Issue": "3", "PubDate": {"Year": "1975", "Month": "Jul"}}, "Title": "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)", "ISOAbbreviation": "Proc Soc Exp Biol Med"}, "ArticleTitle": "Combination chemotherapy of Rauscher leukemia and ascites tumors by narcissus alkaloid with standard drugs and effect on cellular immunity.", "Pagination": {"StartPage": "771", "EndPage": "778", "MedlinePgn": "771-8"}, "Abstract": {"AbstractText": ["The therapeutic activity of the narcissus residual alkaloid A-2 against Rauscher leukemia has been compared with 10 standard anticancer drugs, and synergistic or additive combination pairs have been selected using a viral leukemia and two transplantable tumor systems. An increased beneficial effect has been demonstrated by a combination of the alkylating and DNA-binding agents and the alkaloid against the three malignant tumors, while a beneficial effect by combining the alkaloid and the antimetabolites (either 6-MP or 5-azacytidine) was seen only against the viral leukemia. The alkaloid has no suppressive activity against cellular immunity as tested by PHA reactivity and allogeneic tumor rejection systems."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Furusawa", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Suzuki", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Furusawa", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lee", "ForeName": "J Y", "Initials": "JY"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Soc Exp Biol Med", "NlmUniqueID": "7505892", "ISSNLinking": "0037-9727"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "1CC1JFE158", "NameOfSubstance": "Dactinomycin"}, {"RegistryNumber": "261Q3JB310", "NameOfSubstance": "Streptonigrin"}, {"RegistryNumber": "5J49Q6B70F", "NameOfSubstance": "Vincristine"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "M801H13NRU", "NameOfSubstance": "Azacitidine"}, {"RegistryNumber": "U68WG3173Y", "NameOfSubstance": "Carmustine"}, {"RegistryNumber": "X8D5EPO80M", "NameOfSubstance": "Emetine"}, {"RegistryNumber": "YL5FZ2Y5U1", "NameOfSubstance": "Methotrexate"}, {"RegistryNumber": "ZS7284E0ZP", "NameOfSubstance": "Daunorubicin"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Azacitidine"}, {"QualifierName": [], "DescriptorName": "Blood Cells"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Ehrlich Tumor"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Carmustine"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Dactinomycin"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Daunorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Emetine"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia, Experimental"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia, Lymphoid"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Methotrexate"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rauscher Virus"}, {"QualifierName": [], "DescriptorName": "Spleen"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Streptonigrin"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Vincristine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1975", "Month": "7", "Day": "1"}, {"Year": "1975", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1975", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["49897", "10.3181/00379727-149-38896"]}}]}